The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus

References

• Chang-Quan H, Bi-Rong D, Ping H, Zhen-Chan L. Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus. J Bone Miner Metab. 2008;26(6):561–568. doi:10.1007/s00774-008-0867-z
   Web of Science ®Google Scholar
• Nishtala R, Kietsiriroje N, Karam M, Ajjan RA, Pearson S. Estimated glucose disposal rate demographics and clinical characteristics of young adults with type 1 diabetes mellitus: a cross-sectional pilot study. Vascular Dis Res. 2020;17(5):1479164120952321. doi:10.1177/1479164120952321
   Web of Science ®Google Scholar
• Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626–632. doi:10.2337/diabetes.49.4.626
   PubMed Web of Science ®Google Scholar
• O’Mahoney LL, Kietsiriroje N, Pearson S. Estimated glucose disposal rate as a candidate biomarker for thrombotic biomarkers in T1D: a pooled analysis. J Endocrinol Investig. 2021;44(11):2417–2426. doi:10.1007/s40618-021-01550-3
   Web of Science ®Google Scholar
• Chillarón JJ, Goday A, Flores-Le-Roux JA, et al. Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes. J Clin Endocrinol Metab. 2009;94(9):3530–3534. doi:10.1210/jc.2009-0960
   PubMed Web of Science ®Google Scholar
• Zabala A, Darsalia V, Lind M, et al. Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study. Cardiovasc Diabetol. 2021;20(1):202. doi:10.1186/s12933-021-01394-4
   Web of Science ®Google Scholar
• Nyström T, Holzmann MJ, Eliasson B, Svensson AM, Kuhl J, Sartipy U. Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting. Heart and Vessels. 2017;32(3):269–278. doi:10.1007/s00380-016-0875-1
   Web of Science ®Google Scholar
• Komosinska-Vassev K, Gala O, Olczyk K, Jura-Półtorak A, Olczyk P. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity. Biomolecules. 2020;10(9). doi:10.3390/biom10091304
   Web of Science ®Google Scholar
• Madan R, Gupt B, Saluja S, Kansra UC, Tripathi BK, Guliani BP. Coagulation profile in diabetes and its association with diabetic microvascular complications. J Assoc Physicians India. 2010;58:481–484.
   PubMedGoogle Scholar
• Grant PJ. Diabetes mellitus as a prothrombotic condition. J Intern Med. 2007;262(2):157–172. doi:10.1111/j.1365-2796.2007.01824.x
   PubMed Web of Science ®Google Scholar
• Morange PE, Alessi MC. Thrombosis in central obesity and metabolic syndrome: mechanisms and epidemiology. Thromb Haemost. 2013;110(4):669–680. doi:10.1160/TH13-01-0075
   PubMed Web of Science ®Google Scholar
• Hörber S, Lehmann R, Stefan N, et al. Hemostatic alterations linked to body fat distribution, fatty liver, and insulin resistance. Mol Metab. 2021;53:101262. doi:10.1016/j.molmet.2021.101262
   Web of Science ®Google Scholar
• Yoshida K, Kimura T, Aoki T, et al. Fasting serum insulin levels and insulin resistance are associated with blood rheology in Japanese young adults without diabetes. J Int Med Res. 2016;44(3):496–507. doi:10.1177/0300060515627561
   Web of Science ®Google Scholar
• Temelkova-Kurktschiev T, Siegert G, Bergmann S, et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism. 2002;51(6):743–749. doi:10.1053/meta.2002.32804
   PubMed Web of Science ®Google Scholar
• Kahn SE, Zinman B, Haffner SM, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes. 2006;55(8):2357–2364. doi:10.2337/db06-0116
   Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• National High Blood Pressure Education Program. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157(21):2413–2446. doi:10.1001/archinte.1997.00440420033005
   PubMedGoogle Scholar
• Ephraim RK, Awuku YA, Adu P, et al. High risk of coagulopathy among Type-2 Diabetes Mellitus clients at a municipal hospital in Ghana. Ghana Med J. 2017;51(3):101–107. doi:10.4314/gmj.v51i3.2
   Google Scholar
• Sauls DL, Banini AE, Boyd LC, Hoffman M. Elevated prothrombin level and shortened clotting times in subjects with type 2 diabetes. J Thrombosis Haemostasis. 2007;5(3):638–639. doi:10.1111/j.1538-7836.2007.02366.x
   Web of Science ®Google Scholar
• Erem C, Hacihasanoğlu A, Celik S, et al. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications. Med Principles Practice. 2005;14(1):22–30. doi:10.1159/000081919
   PubMed Web of Science ®Google Scholar
• Sapkota B, Shrestha SK, Poudel S. Association of activated partial thromboplastin time and fibrinogen level in patients with type II diabetes mellitus. BMC Res Notes. 2013;6:485. doi:10.1186/1756-0500-6-485
   Google Scholar
• Agarwal C, Bansal K, Pujani M, et al. Association of coagulation profile with microvascular complications and glycemic control in type 2 diabetes mellitus - a study at a tertiary care center in Delhi. Hematol Transfusion Cell Therapy. 2019;41(1):31–36. doi:10.1016/j.htct.2018.05.002
   Google Scholar
• Ebrahim H, Asrie F, Getaneh Z. Basic Coagulation Profiles and Platelet Parameters Among Adult Type 1 and Type 2 Diabetes Patients at Dessie Referral Hospital, Northeast Ethiopia: comparative Cross-Sectional Study. J Blood Med. 2021;12:33–42. doi:10.2147/JBM.S287136
   PubMed Web of Science ®Google Scholar
• Tonks KT, White CP, Center JR, Samocha-Bonet D, Greenfield JR. Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity. J Clin Endocrinol Metab. 2017;102(4):1112–1121. doi:10.1210/jc.2016-3282
   PubMed Web of Science ®Google Scholar
• Lemkes BA, Hermanides J, Devries JH, Holleman F, Meijers JC, Hoekstra JB. Hyperglycemia: a prothrombotic factor? J Thrombosis Haemostasis. 2010;8(8):1663–1669. doi:10.1111/j.1538-7836.2010.03910.x
   PubMed Web of Science ®Google Scholar
• Barillari G, Fabbro E, Pasca S, Bigotto E. Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population. Blood Coagulation Fibrinolysis. 2009;20(4):290–296. doi:10.1097/MBC.0b013e328329e49b
   Web of Science ®Google Scholar
• Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2(8506):533–537. doi:10.1016/S0140-6736(86)90111-X
   PubMed Web of Science ®Google Scholar
• Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342(8879):1076–1079. doi:10.1016/0140-6736(93)92062-X
   PubMed Web of Science ®Google Scholar
• Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost. 1998;79(1):8–13. doi:10.1055/s-0037-1614250
   Web of Science ®Google Scholar
• Dunn EJ, Grant PJ. Type 2 diabetes: an atherothrombotic syndrome. Curr Mol Med. 2005;5(3):323–332. doi:10.2174/1566524053766059
   Web of Science ®Google Scholar
• Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet dysfunction in type 2 diabetes. Diabetes Care. 2001;24(8):1476–1485. doi:10.2337/diacare.24.8.1476
   PubMed Web of Science ®Google Scholar
• Stary CM, Xu L, Li L, et al. Inhibition of miR-181a protects female mice from transient focal cerebral ischemia by targeting astrocyte estrogen receptor-α. Mol Cell Neurosci. 2017;82:118–125. doi:10.1016/j.mcn.2017.05.004
   Web of Science ®Google Scholar
• de Rivero Vaccari JP, Patel HH, Brand FJ 3rd, Perez-Pinzon MA, Bramlett HM, Raval AP. Estrogen receptor beta signaling alters cellular inflammasomes activity after global cerebral ischemia in reproductively senescence female rats. J Neurochem. 2016;136(3):492–496. doi:10.1111/jnc.13404
   Web of Science ®Google Scholar
• Ernst E, Resch KL, Uher EM. Reviewer bias. Ann Intern Med. 1992;116(11):958. doi:10.7326/0003-4819-116-11-958_2
   Web of Science ®Google Scholar
• Juhan-Vague I, Thompson SG, Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome. A Study of 1500 Patients with Angina Pectoris the ECAT Angina Pectoris Study Group. Arteriosclerosis Thrombosis. 1993;13(12):1865–1873.
   PubMed Web of Science ®Google Scholar
• Dab H, Hachani R, Hodroj W, Sakly M, Bricca G, Kacem K. Differential control of MMP and t-PA/PAI-1 expressions by sympathetic and renin-angiotensin systems in rat left ventricle. Autonomic Neurosci. 2009;150(1–2):27–32. doi:10.1016/j.autneu.2009.04.002
   PubMed Web of Science ®Google Scholar